# An Exploratory Clinical Study of GC012F Injection for Refractory gMG

> **NCT06419166** · EARLY_PHASE1 · WITHDRAWN · sponsor: **Zhejiang University**

## Conditions studied

- Refractory Generalized Myasthenia Gravis

## Interventions

- **DRUG:** GC012F injection

## Key facts

- **NCT ID:** NCT06419166
- **Lead sponsor:** Zhejiang University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2024-12-01
- **Primary completion:** 2027-06-01
- **Final completion:** 2027-10-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** The study stopped early, before enrolling its first participant.
- **Last updated:** 2025-06-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06419166

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06419166, "An Exploratory Clinical Study of GC012F Injection for Refractory gMG". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT06419166. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*